Financial Year |
March 31 2023 |
Monetary Funds |
2,640,888,696.33 |
Held-for-trading Financial Assets |
301,351,013.89 |
Notes Receivable |
31,348,584.07 |
Accounts Receivable |
1,898,902,403.21 |
Advances to Suppliers |
357,264,210.05 |
Other Receivables |
217,879,564.33 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
133,308,870.55 |
Inventories |
783,623,224.61 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
298,541,458.31 |
Total Current Assets |
9,347,789,685.41 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,512,094,893.71 |
Investment Properties |
13,014,698.87 |
Fixed Assetes |
4,341,891,885.10 |
Under-construction Projects |
213,070,545.40 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
3,028,712,404.89 |
R&D expenses |
-- |
Goodwill |
84,109.46 |
Long-Term Deferred and Prepaid Expenses |
59,634,563.71 |
Deferred Income Tax Assets |
187,115,638.79 |
Other Non-Current Assets |
757,463,158.21 |
Sub-Total of Non-Current Assets |
12,434,401,347.38 |
Total Assets |
21,782,191,032.79 |
Short-Term Loans |
960,066,696.56 |
Trading Financial liabilities |
-- |
Notes Payable |
856,196,791.53 |
Accounts Payable |
3,256,731,921.64 |
Accounts Received In Advance |
8,395,357.67 |
Employee Compensation Payable |
69,276,452.54 |
Taxes Payable |
103,372,670.79 |
Interest Payable |
-- |
Dividend Payable |
123,998,040.66 |
Other payables |
315,437,075.84 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
110,877,875.83 |
Other Current Liabilities |
1,272,843,205.02 |
Sub-Total of Current Liabilities |
7,718,253,126.79 |
Long-term Loans |
2,197,749,000.00 |
Bonds Payable |
1,600,000,000.00 |
Long-Term Accounts Payable |
329,458,342.67 |
Special Payable |
-- |
Estimatied Liabilities |
2,414.40 |
Deferred Income Tax Liabilities |
171,942,188.42 |
Other Non-Current Liabilities |
87,888,641.73 |
Sub-Total of Non-Current Liabilities |
4,616,274,685.28 |
Total Liabilities |
12,334,527,812.07 |
Paid-In Capital(Or Share Stock) |
943,894,086.00 |
Capital Surplus |
187,695,233.10 |
Surplus Reserve |
429,911,810.74 |
LESS:Treasury Stock |
57,603,206.89 |
Undistributed Profits |
5,099,970,424.59 |
Minority Stockholder's Interest |
1,436,157,820.96 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,011,505,399.76 |
Owner's Equity(Stockholder's Equity) |
9,447,663,220.72 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
21,782,191,032.79 |